User Overview

What can the inspection of select drugmaking units hope to achieve?

@moneycontrolcom

#UzbekistanCoughSyrupCase | Experts point out that laxity on the part of drug regulators has resulted in substandard & adulterated drugs hitting markets in India & other countries with weak regulatory oversight.

@SumiSukanya tells us more 👇
moneycontrol.com/news/trends/wh…

#Uzbekistan

@SumiSukanya

Red-faced over back-to-back allegations of contamination in #coughsyrups supplied outside #India, @CDSCO_INDIA_INF hs started inspection of identified drugmaking units. A knee-jerk reaction or serious effort to fill gaps?
moneycontrol.com/news/trends/wh…

@binoy_prabhakar @WritesRavi

@SumiSukanya

A total of 19,227 international pax screened betwn Dec 24- Jan 3 for #COVID-19, 124 found +ve. 11 #SARSCoV2 #Omicron variants so far, mostly #XBB :@MoHFW_INDIA

@Moneycontrol
@binoy_prabhakar

Sumi Dutta Retweeted ·

Sheela Bhatt शीला भट्ट

@sheela2010

Possibly sensitive media. Public access unavailable.

@SumiSukanya

On Tuesday, #KeralaHighCourt wl pass final order in the #Ribociclib case, a @Novartis drug for HER2 negative #breastcancer patients. Read how the judgement, either way, cd seal the fate fr thousands of patients of this cancer in India.

@binoy_prabhakar @WritesRavi

@moneycontrolcom

The Kerala HC is scheduled to pass the final order on a first-of-its-kind petition filed by a breast cancer patient seeking judicial intervention to nudge the govt to help lower the cost of Ribociclib, a critical anti-cancer drug.

Read 👇
moneycontrol.com/news/trends/br…

by @SumiSukanya

@SumiSukanya

#HappyNewYear2023 !

Sumi Dutta Retweeted ·

@moneycontrolcom

A four-member panel under Dr Y K Gupta, which was earlier tasked by the government to investigate the deaths of 70 Gambian kids, is likely to be asked to also probe the latest case involving #MarionBiotech.

Read Here 👇🏻
moneycontrol.com/news/trends/te…

#CoughSyrupDeaths |✍️ @SumiSukanya

@SumiSukanya

Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing: @mansukhmandviya

Sumi Dutta Retweeted ·

@moneycontrolcom

#Uzbekistan’s Health Ministry has claimed that at least 18 children died after consuming a #coughsyrup manufactured by Noida-based #MarionBiotech.

India has initiated a joint inspection of Marion Biotech's Noida facility.

Find out more | @SumiSukanya

Possibly sensitive media. Public access unavailable.

Aloke Bajpai

@alokebajpai

Back from Vipassana at Bodh Gaya. Feeling reborn.
10 days without a smartphone and talking, 11 hours a day of meditation and returning with the realisation that we know nothing about ourselves till we "experience" the state of equanimity.

@SumiSukanya

Replying to @alokebajpai

Have been thinking about it. Does it help alleviate the stress related to everyday living later?

Sumi Dutta Retweeted ·

Uzbekistan cough syrup case: Govt may order category-wise halt of drug production based on probe findings

@moneycontrolcom

The batches of cough syrup linked to the deaths of 18 kids in Uzbekistan had been exported by Noida-based Marion Biotech to the central Asian country in May 2021

Read Here 👇🏻
moneycontrol.com/news/trends/uz…

#Uzbekistan #CoughSyrupDeaths | ✍️ @SumiSukanya

@SumiSukanya

Outside #MarionBiotech, the company which has been blamed by #Uzbekistan for supplying contaminated cough syrup that may have killed 18 kids there.

@binoy_prabhakar @WritesRavi

Possibly sensitive media. Public access unavailable.

@SumiSukanya

#MarionBiotech is in the eye of a storm after #Uzbekistan blamed its cough syrups for deaths of 18 kids. #India is now testing all its drugs, mainly syrups, suspensions for possible contamination

@binoy_prabhakar @WritesRavi

moneycontrol.com/news/trends/he…

Sumi Dutta Retweeted ·

In reply to @mansukhmandviya

Dr Mansukh Mandaviya

@mansukhmandviya

The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory, Chandigarh for testing. (3/3)

Sumi Dutta Retweeted ·

Kumar Anshuman

@anshumanscribe

Apology Notice in ⁦@timesofindia⁩ today.

Possibly sensitive media. Public access unavailable.

Sumi Dutta Retweeted ·

In reply to @SrBachchan

Dr Arun Gupta MD FIAP

@Moveribfan

@SrBachchan these biscuits are addictive by its nature , here is the evidence. onlinelibrary.wiley.com/doi/10.1111/ad… @RemaNagarajan @jagritichandra @AnonnaDutt @ScienceTales @Mukesh_k @Banjotkaur @SumiSukanya @archie_dear @chetanecostani @chetanabelagere @raman_anuradha @snehamordani

Possibly sensitive media. Public access unavailable.

Sumi Dutta Retweeted ·

@moneycontrolcom

The Central Drugs Standard Control Organisation has started conducting a joint inspection of identified drug manufacturing units along with state drug control administrations in a risk-based approach.

@SumiSukanya brings more details 👇
moneycontrol.com/news/trends/dr…

#CDSCO #Drugs

@SumiSukanya

#Imp: @CDSCO_INDIA_INF along with state drug administrators to inspect identified drug making units across #India at risk of making NSQ/ spurious drugs for #GMP violations.

#MaidenPharma
#CoughSyrupDeaths

Sumi Dutta Retweeted ·

Sonal MehrotraKapoor

@Sonal_MK

Nasal Vaccine to cost upto ₹1000 per dose

#BharatBiotech #Booster

MC Exclusive by @SumiSukanya

moneycontrol.com/news/trends/mc…

Sumi Dutta Retweeted ·

@moneycontrolcom

Here's how much a single dose of Bharat Biotech’s intranasal vaccine #iNCOVACC will cost you in private hospitals👇

moneycontrol.com/news/trends/mc…

@SumiSukanya ✍️ | #COVID19 #COVID19Vaccine

MC Exclusive | Bharat Biotechs intranasal COVID-19 vaccine will cost Rs 800 plus 5% GST per dose to private hospitals

@SumiSukanya

#PrivateHospitals will get to buy @BharatBiotech's #nasalvaccine at Rs 800+5 % GST/ dose; as hospitals can charge upto Rs 150 admin charges- you may need to pay around Rs 1000 for every dose. Our exclusive

moneycontrol.com/news/trends/mc…

@binoy_prabhakar @WritesRavi @chandrarsrikant

Vinod Scaria

@vinodscaria

Looks like Indian media has gone bonkers over BF.7 🤦‍♂️
Why this kolaveri di ? pic.twitter.com/V22jr6PS9g

@SumiSukanya

Replying to @vinodscaria

🤣

In reply to @mansukhmandviya

@SumiSukanya

@mansukhmandviya holding a #COVID review meeting with state health ministers

#coronavirus #ChinaCovidCases

Possibly sensitive media. Public access unavailable.

In reply to @MoHFW_INDIA

@SumiSukanya

@MoHFW_INDIA wants people to take booster doses of #CovidVaccines but has less than 1 crore shots in its kitty and no plans to procure more in the near future for public hospitals. Read our #Exclusive

@binoy_prabhakar @WritesRavi

#coronavirus #ChinaCovidCases

@moneycontrolcom

#MCExclusive | Amid the growing #COVID19 scare and increasing public demand for vaccines, the Union government is staring at a stockout, with less than 1 crore shots left in its kitty.

Read on⤵️
moneycontrol.com/news/trends/ex…

By @SumiSukanya | #CovidVaccine #Vaccine #COVID #India

Sumi Dutta Retweeted ·

Bharat Biotech's nasal Covid vaccine enters India's booster shots list

@moneycontrolcom

#BharatBiotech's nasal #COVID19 vaccine is to now be included as a #booster dose in India's immunisation drive against coronavirus.

Can the ones fully vaccinated with Covaxin or Covishield take it? Find out from @SumiSukanya 👇
moneycontrol.com/news/coronavir…

#COVID19Vaccine

@SumiSukanya

#JustIn: @MoHFW_INDIA to include nasal #COVIDvaccine by @BharatBiotech in Immunization drive against as a #boostershot.

It will now be offered in pvt hospitals to adults earlier fully vaccinated with #Covaxin, #Covishield after the government makes changes in #CoWin

Sumi Dutta Retweeted ·

@moneycontrolcom

The situation in #China has triggered global concern even though there is a lack of specific data on disease severity, hospital admissions and intensive-care requirements.

#MCExplains: Why #COVID19 is spiking in China? Know 👇
moneycontrol.com/news/trends/mc…

by @SumiSukanya

Possibly sensitive media. Public access unavailable.

@SumiSukanya

#JustIn: @MoHFW_INDIA asks Civil Aviation ministry to ensure that samples of 2% of pax in every flight inbound to #India is tested for #COVID19. If found +ve, these samples to be subjected to genomic sequencing, pax can leave airports after submitting samples

@binoy_prabhakar

Sumi Dutta Retweeted ·

Dr Ishwar Gilada

@drgilada

My daughter Dr Trupti Gilada's views on current status of Covid-19

moneycontrol.com/news/trends/mc…

@SumiSukanya

Read it to understand why #COVID is back in global spotlight after a long lull.

#COVID19
@binoy_prabhakar @WritesRavi

#China

@moneycontrolcom

@SumiSukanya

👇This message on #XBB variant circulating on #WhatsApp groups is #Fake, says @Mohfw.

#COVID19
#CovidIsNotOver
#CovidVaccines

Possibly sensitive media. Public access unavailable.

Sumi Dutta Retweeted ·

COVID-19: Fresh push to booster shots for adults; focus this time on mix-and- match doses

@moneycontrolcom

Is a mix and match of COVID-19 vaccines the new hope? 💉

Here's what experts say 👇
moneycontrol.com/news/trends/co…

@SumiSukanya ✍️ | #COVID19 #Coronavirus #Booster #COVID19india #Vaccines #ChinaCovid

@SumiSukanya

Masks are back. @mansukhmandviya reviews status in India as #COVID rips through #China

#COVID19 #CovidIsntOver

Possibly sensitive media. Public access unavailable.

@SumiSukanya

World is anxious as #China moves from #ZeroCOVIDpolicy to No Covid Policy. What can #India expect? Read what experts say

#chinacovid
@binoy_prabhakar @WritesRavi @GKangInd @AnuragAgrawalMD

@moneycontrolcom

As on December 20, the country had recorded 10,072, 004 infections while the number of deaths stood at 31,309 as per official figures.

Read Here 👇🏻
moneycontrol.com/news/trends/ch…

#China #Covid19 | ✍️ @SumiSukanya

@SumiSukanya

People tend to see air pollution as a major problem only when the #AQI is in the severe category but that is a complete misnomer, says Dr Arvind Kumar of @medanta. Read this piece to understand why India needs urgent action to tackle #AirPollution.

@binoy_prabhakar @WritesRavi

@moneycontrolcom

With strong north-westerly winds improving #AirQuality in #Delhi-NCR marginally over the last few weeks, residents gasping for clean air are heaving a sigh of relief. But top doctors have a warning.

Read on⬇️
moneycontrol.com/news/trends/do…

By @SumiSukanya | #AirQualityIndex #Pollution

Sumi Dutta Retweeted ·

Don't breathe easy over AQI improvement, air pollution is not just a seasonal problem: Dr Arvind Kumar

@moneycontrolcom

Stem cell therapy not recommended for autistic kids: NMC

@SumiSukanya

Over 100 centers in #India sell #StemCellTherapy to gullible parents looking for cure for their autistic kids, exploiting lacuna in reg norms. @NMC_IND now draws line for erring #doctors. Do read this imp report

@binoy_prabhakar @WritesRavi
@drsitu

moneycontrol.com/news/trends/st…

SanjayKJha

@whoskj2

My son would have turned 27 today. I was told earlier this year he died in a road accident in Mohali. Police did no investigation; closure report was a pack of lies. You can't expect justice from any government @PunjabPoliceInd @DGPPunjabPolice @CMOPb @ArvindKejriwal pic.twitter.com/iamMtyLUo2

@SumiSukanya

Replying to @whoskj2 @PunjabPoliceInd and 3 others

Can't even imagine your pain. I hope there are at least some kind people in @PunjabPoliceInd who will take note and help him get justice.

Sumi Dutta Retweeted ·

SanjayKJha

@whoskj2

Possibly sensitive media. Public access unavailable.

Sumi Dutta Retweeted ·

India nowhas most comprehensive TB test; can check sensitivity to 18 antibiotics

@moneycontrolcom

HaystackAnalytics, a health-tech startup incubated at the IIT - Bombay, has collaborated with healthcare solution provider LifeCell to offer India’s first genetic test diagnosing drug-resistant #TB.

All you need to know about the test:
moneycontrol.com/news/trends/in…

@SumiSukanya ✍️

Two key drugs for drug resistant TB are now essential medicines. But will patients benefit?

Sumi Dutta Retweeted ·

Anup Soans

@anupsoans

India has the highest burden of TB and MDR-TB in the world, disproportionately high even for India’s population.

As per the annual TB report, India had a total of 19,33,381 new and relapsed patients with TB in 2021.

This also included nearly 1,20,000 MDR TB patients

Sumi Dutta Retweeted ·

Salil Kallianpur

@salilkallianpur

TB drugs have been given free for years and yet India is home to MDR/XDR TB. Govt answer? Price control for patented drugs.

Two key drugs for drug resistant TB are now essential medicines. But will patients benefit? moneycontrol.com/news/trends/tw…

@SumiSukanya

#Bedaquiline and #Delamanid were two crucial #Tuberculosis drugs among four drugs still under #patent that have been put on the essential medicine list by @MoHFW_INDIA.But will it aid patients' fight in accessing them?Read on

moneycontrol.com/news/trends/tw…

@binoy_prabhakar @WritesRavi

@SumiSukanya

A #diabetes drug that is helping many shed kilos quickly has caught the fancy of the rich and commoners alike world over but its high cost in #India is a deterrent for most. Read our report
moneycontrol.com/news/trends/di…

@binoy_prabhakar @WritesRavi

Sumi Dutta Retweeted ·

NDTV

@ndtv

#TheNews | Mumbai witnesses the highest air pollution in 5 years.

Possibly sensitive media. Public access unavailable.

@SumiSukanya

#Paediatricians chart the weight and height of #kids from birth, which is expressed in percentiles based on @WHO standards to assess whether a child is growing well. But soon there will be #India specific standards for this. An interesting report

@binoy_prabhakar @WritesRavi

@moneycontrolcom

The Indian government has initiated moves to develop growth standards for children amid concerns that the weight and height references recommended by WHO may not be suitable in the Indian context.

Know more⤵️
moneycontrol.com/news/trends/in…

By @SumiSukanya | #India #Malnutrition #WHO

Sumi Dutta Retweeted ·

Rajeev Jayadevan

@RajeevJayadevan

Dementia cure remains elusive. The latest trial of a dementia medication yielded mixed results. Although it reduced the amyloid burden in the brain, the clinical benefit to patients was minimal. I am quoted in this article by @SumiSukanya

moneycontrol.com/news/trends/mc…

Sumi Dutta Retweeted ·